OBJECTIVE To evaluate the effect of baseline bleeding patterns on rates of amenorrhea reported at 12 months in LNG (levonorgestrel) 52 mg IUS (intrauterine system) users. We also assessed the effect of baseline bleeding patterns at three and six months post-insertion. STUDY DESIGN In this secondary analysis of the Contraceptive CHOICE Project, we included participants who had a LNG-IUS inserted within one month of enrollment and continued use for 12 months. Using 12-month telephone survey data, we defined amenorrhea at 12 months of use as no bleeding or spotting during the previous six months. We used chi-square and multivariable logistic regression to assess the association of baseline bleeding pattern with amenorrhea while controllin...
PURPOSE:Evaluate bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system (IUS) u...
Background: Objective of the study was to find out improvement in menstrual symptoms with Levonorges...
Background: Heavy menstrual bleeding (HMB) is defined as prolonged (>7 days) or excessive menstru...
OBJECTIVE:The objective was to evaluate amenorrhea patterns and predictors of amenorrhea during the ...
ObjectiveCompare bleeding patterns for levonorgestrel 52 mg, 19.5 mg, and 13.5 mg intrauterine syste...
BackgroundThe levonorgestrel 52-mg intrauterine system has proven efficacy for heavy menstrual bleed...
OBJECTIVE: The study was conducted to identify predictors of oligoamenorrhea at 12 months in levonor...
Background: To study the efficacy, performance and acceptability of levonorgestrel intrauterine devi...
AbstractBackgroundThe study was conducted to assess outcomes among women using the levonorgestrel-re...
The objectives of this study were to evaluate the bleeding patterns and clinical performance during ...
ABSTRACT Objective: To determine from the literature whether it is safe for women with heavy or prol...
Background: Menorrhagia, menstrual blood loss of more than 80 ml is a common health problem affectin...
Background: Changes in menstrual bleeding patterns are a major cause of hormonal contraceptive disco...
BACKGROUND: Levonorgestrel-releasing intrauterine system (LNG-IUS), although inserted to reduce heav...
Objectives: Up to 60% of women remove their levonorgestrel-releasing Intrauterine System (LNG-IUS) p...
PURPOSE:Evaluate bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system (IUS) u...
Background: Objective of the study was to find out improvement in menstrual symptoms with Levonorges...
Background: Heavy menstrual bleeding (HMB) is defined as prolonged (>7 days) or excessive menstru...
OBJECTIVE:The objective was to evaluate amenorrhea patterns and predictors of amenorrhea during the ...
ObjectiveCompare bleeding patterns for levonorgestrel 52 mg, 19.5 mg, and 13.5 mg intrauterine syste...
BackgroundThe levonorgestrel 52-mg intrauterine system has proven efficacy for heavy menstrual bleed...
OBJECTIVE: The study was conducted to identify predictors of oligoamenorrhea at 12 months in levonor...
Background: To study the efficacy, performance and acceptability of levonorgestrel intrauterine devi...
AbstractBackgroundThe study was conducted to assess outcomes among women using the levonorgestrel-re...
The objectives of this study were to evaluate the bleeding patterns and clinical performance during ...
ABSTRACT Objective: To determine from the literature whether it is safe for women with heavy or prol...
Background: Menorrhagia, menstrual blood loss of more than 80 ml is a common health problem affectin...
Background: Changes in menstrual bleeding patterns are a major cause of hormonal contraceptive disco...
BACKGROUND: Levonorgestrel-releasing intrauterine system (LNG-IUS), although inserted to reduce heav...
Objectives: Up to 60% of women remove their levonorgestrel-releasing Intrauterine System (LNG-IUS) p...
PURPOSE:Evaluate bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system (IUS) u...
Background: Objective of the study was to find out improvement in menstrual symptoms with Levonorges...
Background: Heavy menstrual bleeding (HMB) is defined as prolonged (>7 days) or excessive menstru...